Marie-Agnès Dragon-Durey
Dragon-Durey, Marie-Agnès
VIAF ID: 290080348 (Personal)
Permalink: http://viaf.org/viaf/290080348
Preferred Forms
- 100 1 _ ‡a DRAGON DUREY, MARIE-AGNES,
- 100 1 _ ‡a Dragon-Durey, Marie-Agnès
- 100 1 _ ‡a Dragon-Durey, Marie-Agnès
- 100 0 _ ‡a Marie-Agnès Dragon-Durey
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies | |
Alternative complement pathway assessment in patients with atypical HUS. | |
Application of Deamidated Gliadin Antibodies in the Follow-Up of Treated Celiac Disease. | |
Atypical aHUS: State of the art. | |
Auto-immunité et gestion des toxicités des traitements par anti-check point inhibiteurs. | |
Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy | |
C5 nephritic factors drive the biological phenotype of C3 glomerulopathies | |
Complement deficiencies and human diseases | |
Déficits en protéines du complément en pathologie humaine | |
Diagnostic biologique du syndrome des antiphospholipides : des critères à la pratique | |
Eculizumab for atypical hemolytic-uremic syndrome in India: First report from India and the challenges faced. | |
Eculizumab reversed severe distal ischemic syndrome and glomerulonephritis with isolated C3 deposits associated with anti-factor H autoantibodies: a case report | |
An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H. | |
Etude de nouveaux tests sérologiques dans le diagnostic et le suivi de la maladie cœliaque | |
Une étude translationnelle de la néphropathie à IgA de l'enfant : des variants génétiques à la physiopathologie des biomarqueurs et leurs liens de causalité avec les lésions histologiques | |
Expression of low-affinity Fc gamma receptor by a human metastatic melanoma line. | |
Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis. | |
Functional evaluation of factor H genetic and acquired abnormalities: application for atypical hemolytic uremic syndrome (aHUS). | |
Gastrointestinal pathogens in anti-FH antibody positive and negative Hemolytic Uremic Syndrome | |
Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults | |
The Heat Shock Protein Gp96 in Macrophages during ER stress : Interaction with Complement C3. | |
Hereditary angio-oedema: effective treatment with the progestogen-only pill in a young woman. | |
Heterogeneous pattern of renal disease associated with homozygous Factor H deficiency | |
Immunogénicité du facteur VIII thérapeutique : importance du complément et des domaines C du facteur VIII pour son endocytose | |
Increased Performances of the Biological Diagnosis of the Antiphospholipid Syndrome by the Use of a Multiplex Assay | |
Inhibition of the mTORC pathway in the antiphospholipid syndrome. | |
Investigation of the complement system in clinical practice | |
Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses | |
Lupus nephritis associated with complete C1s deficiency efficiently treated with rituximab: A case report | |
Mise au point, validation analytique et applications d'une méthode de quantification in vitro des auto-anticorps, allo-anticorps et des anticorps thérapeutiques | |
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome | |
Non-Hodgkin’s lymphomas and myeloid disorders: deletions associated with t(2;5) and t(3;5) detected by FISH | |
A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy. | |
Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2 | |
A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function | |
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children | |
RECEPTEURS POUR LA REGION FC DES IMMUNOGLOBULINES ET CELLULES TUMORALES | |
Routinely used immunoassays do not detect circulating anti-GBM antibodies against native NC1 hexamer and EA epitope of the α3 chain of type IV collagen | |
Standardisation of the factor H autoantibody assay | |
Stress proteins HSP90 and Gp96 in graft-versus-host disease : pathophysiological, diagnostic and therapeutic implication. | |
Study of antibodies anti-factor h in atypical hemolytic and uremic syndrome and in membranoproliferative glomerulonephritis. | |
Targeting renin-angiotensin system in malignant hypertension in atypical hemolytic uremic syndrome. | |
Testing anti-neutrophil cytoplasmic antibodies (ANCA): analysis of the European EASI survey on the daily practice of the French laboratories. | |
Therapy for patients with antibodies to complement factor H associated HUS | |
Unusual clinical severity of complement membrane cofactor protein-associated hemolytic-uremic syndrome and uniparental isodisomy | |
Varicella as a trigger of atypical haemolytic uraemic syndrome associated with complement dysfunction: two cases | |
Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population |